New eczema shot for kids enters testing phase
Disease control
Ongoing
This trial is studying a drug called tralokinumab, given as an injection, to see how it behaves in the body and if it is safe and effective for children aged 6 to 12 with moderate-to-severe eczema. It will involve about 24 children and last for up to 194 weeks, including treatmen…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC